Literature DB >> 17088260

Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer.

Emily J Greenspan1, Jennifer L Cyr, Devon C Pleau, Joel Levine, Thiruchandurai V Rajan, Daniel W Rosenberg, Christopher D Heinen.   

Abstract

Aberrant crypt foci (ACF) are microscopic surface abnormalities that are putative precursors to colorectal cancer (CRC). ACF exhibit similar histological and molecular abnormalities to adenomas and CRC and potentially represent useful biomarkers of cancer risk. Microsatellite instability (MSI) is one molecular abnormality identified in concurrent ACF from CRC patients that may indicate a risk for progression. To determine if MSI can be detected in ACF from cancer-free subjects, we examined 45 ACF from 20 subjects undergoing colonoscopies. The group included 12 patients at elevated risk for CRC based on family history of CRC or personal history of CRC or advanced adenoma and 8 patients with no known risk factors. ACF were identified using close-focus magnifying chromendoscopy and collected by biopsy in situ. Genomic DNA was prepared from ACF and adjacent normal colonic epithelium isolated by laser capture microdissection and analyzed for MSI. MSI was identified in at least one marker from 9 of 30 (30%) lesions from patients at elevated risk for CRC and in 2 of 15 (13%) lesions from average risk patients. Using methylation-specific PCR analysis, we also examined the ACF for promoter hypermethylation of the DNA repair genes hMLH1 and MGMT and found moderate changes (8/39 and 3/32, respectively). Although we found only a limited relationship between hMLH1 hypermethylation and MSI, all the lesions with MGMT hypermethylation displayed an MSI-low phenotype. These lesions may be precursors to MSI-low CRC, providing a potential early biomarker to assess the effects of cancer prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088260     DOI: 10.1093/carcin/bgl209

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

1.  HD chromoendoscopy coupled with DNA mass spectrometry profiling identifies somatic mutations in microdissected human proximal aberrant crypt foci.

Authors:  David A Drew; Thomas J Devers; Michael J O'Brien; Nicole A Horelik; Joel Levine; Daniel W Rosenberg
Journal:  Mol Cancer Res       Date:  2014-03-20       Impact factor: 5.852

2.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Authors:  Robert M W Hofstra; Amanda B Spurdle; Diana Eccles; William D Foulkes; Niels de Wind; Nicoline Hoogerbrugge; Frans B L Hogervorst
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

Review 3.  Methods for genome-wide analysis of DNA methylation in intestinal tumors.

Authors:  Maria A Hahn; Gerd P Pfeifer
Journal:  Mutat Res       Date:  2009-10-23       Impact factor: 2.433

Review 4.  Colorectal carcinogenesis: road maps to cancer.

Authors:  Daniel-L Worthley; Vicki-L Whitehall; Kevin-J Spring; Barbara-A Leggett
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

5.  Nanoproteomic analysis of extracellular receptor kinase-1/2 post-translational activation in microdissected human hyperplastic colon lesions.

Authors:  David A Drew; Thomas Devers; Nicole Horelik; Shi Yang; Michael O'Brien; Rong Wu; Daniel W Rosenberg
Journal:  Proteomics       Date:  2013-04-04       Impact factor: 3.984

6.  Topographic, histological and molecular study of aberrant crypt foci identified in human colon in different clinical groups.

Authors:  Shouriyo Ghosh; Brijnandan Gupta; Pavan Verma; Sreenivas Vishnubathla; Sujoy Pal; Nihar R Dash; Siddhartha Datta Gupta; Prasenjit Das
Journal:  Intest Res       Date:  2018-01-18

7.  Relationship Between Human mutL Homolog 1 (hMLH1) Hypermethylation and Colorectal Cancer: A Meta-Analysis.

Authors:  Hui-Feng Zhang; You-Wang Lu; Zhen-Rong Xie; Kun-Hua Wang
Journal:  Med Sci Monit       Date:  2017-06-21

8.  Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer.

Authors:  Michael J Wargovich; Vondina R Brown; Jay Morris
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

9.  Evaluation of chemopreventive potential of Strobilanthes crispus against colon cancer formation in vitro and in vivo.

Authors:  Nawal Al-Henhena; Shaden A M Khalifa; Rozaida Poh Yuen Ying; Salmah Ismail; Riad Hamadi; Abdrabu N Shawter; Azila Mohd Idris; Ainnul Azizan; Nahla Saeed Al-Wajeeh; Mahmood Ameen Abdulla; Hesham R El-Seedi
Journal:  BMC Complement Altern Med       Date:  2015-11-25       Impact factor: 3.659

10.  Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci.

Authors:  Marek Kowalczyk; Piotr Siermontowski; Dariusz Mucha; Tadeusz Ambroży; Marcin Orłowski; Krzysztof Zinkiewicz; Waldemar Kurpiewski; Krzysztof Paśnik; Iwona Kowalczyk; Agnieszka Pedrycz
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.